Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Zhe, Shi, Lei, Wang, Yijin, Zhang, Jiyuan, Huang, Lei, Zhang, Chao, Liu, Shuhong, Zhao, Peng +10 more·2020·The Lancet Respiratory Medicine

Cited by (1,023)

Items 401–500 of 1,023

  1. Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
    Konstantinos E. Farsalinos, RAYMOND S. NIAURA, Jacques Le Houezec, Anastasia Barbouni, Aristidis Michael Tsatsakis, Demetrios Kouretas, Apostolos Vantarakis, Konstantinos A. Poulas · 2020 · Toxicology Reports
  2. Psychological responses during the COVID-19 outbreak among university students in Bangladesh
    Islam, Md. Saiful, Sujan, Md. Safaet Hossain, Tasnim, Rafia, Sikder, Md. Tajuddin, Potenza, Marc N., van Os, Jim · 2020 · PLOS ONE
  3. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
    You Shang, Chun Shui Pan, Xianghong Yang, Ming Zhong, Xiuling Shang, Zhixiong Wu, Zhui Yu, Wei Zhang, Qiang Zhong, Xia Zheng et al. · 2020 · Annals of Intensive Care
  4. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells
    Christoph Muus, Malte D. Luecken, Gökçen Eraslan, Avinash Waghray, Graham Heimberg, Lisa Sikkema, Yoshihiko Kobayashi, Eeshit Dhaval Vaishnav, Ayshwarya Subramanian, Christopher Smilie et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
    Jiajia Chen, Chenxia Hu, Lijun Chen, Lingling Tang, Yixin Zhu, Xiaowei Xu, Lü Chen, Hainv Gao, Xiaoqing Lu, Liang Yu et al. · 2020 · Engineering
  6. Coronaviruses pathogenesis, comorbidities and multi-organ damage – A review
    Kaviyarasi Renu, Pureti Lakshmi Prasanna, Abilash Valsala Gopalakrishnan · 2020 · Life Sciences
  7. Therapeutic management of patients with COVID-19: a systematic review
    Mansour A. Tobaiqy, Mohammed Esmail Qashqary, Shrooq T. Aldahery, Alaa Mujallad, Almonther Abdullah Hershan, Mohammad Azhar Kamal, Nawal Mohammed Helmi · 2020 · Infection Prevention in Practice
  8. Diagnosis of Coronavirus Disease 2019 (COVID-19) With Structured Latent Multi-View Representation Learning
    Hengyuan Kang, Liming Xia, Fuhua Yan, Zhibin Wan, Feng Shi, Huan Yuan, Huiting Jiang, Dijia Wu, He Sui, Changqing Zhang et al. · 2020 · IEEE Transactions on Medical Imaging
  9. Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study
    Guangyao Wu, Pei Yang, Henry C. Woodruff, Xiangang Rao, Julien Guiot, Anne-Noëlle Frix, Michel P. Moutschen, Renaud E. Louis, Jiawei Li, Jiawei Li et al. · 2020 · European Respiratory Journal
  10. Laboratory findings in COVID-19 diagnosis and prognosis
    Atieh Pourbagheri‐Sigaroodi, Davood Bashash, Fatemeh Fateh, Hassan Abolghasemi · 2020 · Clinica Chimica Acta
  11. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
    Chao Shan, Yanfeng Yao, Xing‐Lou Yang, Yiwu Zhou, Ge Gao, Yun Peng, Lian Yang, Xue Hu, Jin Xiong, Ren-Di Jiang et al. · 2020 · Cell Research
  12. Providing pharmacy services during the coronavirus pandemic
    Shao Liu, Ping Luo, Mimi L.K. Tang, Qin Hu, Joseph P. Polidoro, Shusen Sun, Zhicheng Gong · 2020 · International Journal of Clinical Pharmacy
  13. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
    Ashley Barlow, Kaitlin M. Landolf, Brooke Barlow, Siu Yan Amy Yeung, Jason J. Heavner, Cassidy W. Claassen, Mojdeh S. Heavner · 2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  14. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response
    Lucas Leite Cunha, Sandro Félix Perazzio, Jamil Azzi, Paolo Cravedi, Leonardo V. Riella · 2020 · Frontiers in Immunology
  15. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors
    Manvendra Singh, Vikas Bansal, Cédric Feschotte · 2020 · Cell Reports
  16. SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
    Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, Sergio Aguirre‐Sampieri, Alicia Sampieri, Luis A. Vaca · 2021 · Frontiers in Immunology
  17. Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System
    Zhang, Min, Wang, Peng, Luo, Ronghua, Wang, Yaqing, Li, Zhongyu, Guo, Yaqiong, Yao, Yulin, Li, Minghua, Tao, Tingting, Chen, Wenwen et al. · 2021 · Advanced Science
  18. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review
    Jaume Alijotas‐Reig, Enrique Esteve‐Valverde, Cristina C. Belizna, Albert Selva-O’Callaghan, José Pardos‐Gea, Ángela Quintana, Arsène MEKINIAN, Ariadna Anunciación-Llunell, Francesc Miró‐Mur · 2020 · Autoimmunity Reviews
  19. The immunology of COVID-19: is immune modulation an option for treatment?
    Jixin Zhong, Jungen Tang, Cong Ye, Lingli Dong · 2020 · The Lancet Rheumatology
  20. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study
    Feng Pan, Lian Yang, Yuncheng Li, Bo Liang, Li Lin, Tianhe Ye, Lingli Li, Dehan Liu, Shan Gui, Yu Hu et al. · 2020 · International Journal of Medical Sciences
  21. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
    Jiqian Xu, Xiaobo Yang, Luyu Yang, Xiaojing Zou, Yaxin Wang, Yongran Wu, Ting Zhou, Yin Yuan, Hong Qi, Shouzhi Fu et al. · 2020 · Critical Care
  22. Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data
    Stephen M. Lagana, Satoru Kudose, Alina Cornelia Iuga, Michael J. Lee, Ladan Fazlollahi, Helen Elaine Remotti, Armando Del Portillo, Simona De Michele, Anne K. Koehne de Gonzalez, Anjali Saqi et al. · 2020 · Modern Pathology
  23. COVID-19 and Heart Failure: From Infection to Inflammation and Angiotensin II Stimulation. Searching for Evidence from a New Disease
    Daniela Tomasoni, Leonardo Italia, Marianna Adamo, Riccardo Maria Inciardi, Carlo Lombardi, Scott David Solomon, Marco Metra · 2020 · European Journal of Heart Failure
  24. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis
    Rika Kawakami, Atsushi Sakamoto, Kenji Kawai, Andrea Gianatti, Dario Pellegrini, Ahmed Nasr, Bob Kutys, Liang Guo, Anne Cornelissen, Masayuki Mori et al. · 2021 · Journal of the American College of Cardiology
  25. Could Vitamins Help in the Fight Against COVID-19?
    Jovic, Thomas H, Ali, Stephen R, Ibrahim, Nader, Jessop, Zita M, Tarassoli, Sam P, Dobbs, Thomas D, Holford, Patrick, Thornton, Catherine A, Whitaker, Iain S · 2020 · Nutrients
  26. Patterns of IgG and IgM antibody response in COVID-19 patients
    Xuemei Liu, Jing Wang, Xiao-Lei Xu, Guojian Liao, Yaokai Chen, Changhua Hu · 2020 · Emerging Microbes & Infections
  27. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
    Yu Zuo, Mark Warnock, Alyssa Harbaugh, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, Jason S. Knight, Yogendra M. Kanthi, Daniel A. Lawrence · 2021 · Scientific Reports
  28. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2
    Valeria Garcia‐Flores, Roberto J. Romero, Yi Xu, Kevin R. Theis, Marcia Arenas‐Hernandez, Derek Miller, Azam Peyvandipour, Gaurav Bhatti, José Galaz, Meyer Gershater et al. · 2022 · Nature Communications
  29. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019
    Zhao, Hong-Mei, Xie, Yu-Xiao, Wang, Chen · 2020 · Chinese Medical Journal
  30. Novel coronavirus disease (COVID-19) in children
    Hasan Tezer, Tuğba Bedir Demirdağ · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
  31. Gastrointestinal and liver manifestations in patients with COVID-19
    I‐Cheng Lee, Teh‐Ia Huo, Yi‐Hsiang Huang · 2020 · Journal of the Chinese Medical Association
  32. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
    Felicitas La Rosée, Hinrich Bremer, Iris Gehrke, Anna Katharina Kehr, Andreas Hochhaus, Sebastian Birndt, Matthias Fellhauer, Martin Henkes, Bernhard Kumle, Sebastian Giuseppe Russo et al. · 2020 · Leukemia
  33. COVID-19 in cancer patients: risk, clinical features, and management
    Cuiwei Liu, Yanxia Zhao, Derick K. Okwan-Duodu, Reva Kakkar Basho, Xiaojiang Cui · 2020 · Cancer Biology and Medicine
  34. Multi-Task Temporal Shift Attention Networks for On-Device Contactless Vitals Measurement
    Xin Liu, Josh Fromm, Shwetak Patel, Daniel McDuff · 2020 · arXiv (Cornell University)
  35. Preliminary predictive criteria for COVID-19 cytokine storm
    Caricchio, Roberto, Gallucci, Marcello, Dass, Chandra, Zhang, Xinyan, Gallucci, Stefania, Fleece, David, Bromberg, Michael, Criner, Gerard J · 2021 · Annals of the Rheumatic Diseases
  36. Coagulation and anticoagulation in COVID-19
    Tarik H. Hadid, Zyad Kafri, Ayad Al-Katib · 2020 · Blood Reviews
  37. Immune-epidemiological parameters of the novel coronavirus – a perspective
    Amene Saghazadeh, Nima Rezaei · 2020 · Expert Review of Clinical Immunology
  38. Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists
    Marina Carotti, Fausto Salaffi, Piercarlo Sarzi‐Puttini, Andrea Agostini, Alessandra Borgheresi, Davide Minorati, Massimo Galli, Daniela Marotto, Andrea Giovagnoni · 2020 · La radiologia medica
  39. An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells
    Lamers, Mart M, van der Vaart, Jelte, Knoops, Kèvin, Riesebosch, Samra, Breugem, Tim I, Mykytyn, Anna Z, Beumer, Joep, Schipper, Debby, Bezstarosti, Karel, Koopman, Charlotte D et al. · 2021 · The EMBO Journal
  40. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients
    Ojha, Vineeta, Mani, Avinash, Pandey, Niraj Nirmal, Sharma, Sanjiv, Kumar, Sanjeev · 2020 · European Radiology
  41. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes
    Emmanouil Korakas, Ignatios Ikonomidis, Foteini Kousathana, Konstantinos Balampanis, Aikaterini Kountouri, Athanasios E. Raptis, Lina Palaiodimou, Alexander D. Kokkinos, Vaia Lambadiari · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  42. Severe COVID-19: NLRP3 Inflammasome Dysregulated
    Daan F. van den Berg, Anje A. te Velde · 2020 · Frontiers in Immunology
  43. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic
    Maryam Sharifian, Philippe Huot, Michael Osherov, Dingke Wen, Alexander Saveriano, Paul Steven Giacomini, Jack Perry Antel, Ashkan Mowla · 2020 · Journal of the Neurological Sciences
  44. Cardiovascular Manifestations of COVID-19 Infection
    Ajit Magadum, Raj Kishore · 2020 · Cells
  45. Review article: COVID‐19 and liver disease—what we know on 1st May 2020
    Isabel Garrido, Rodrigo Liberal, Guilherme Macedo · 2020 · Alimentary Pharmacology & Therapeutics
  46. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
    Massimo Imazio, Karin Klingel, Ingrid Kindermann, Antonio Luca Brucato, Francesco Giuseppe De Rosa, Yehuda Adler, Gaetano Maria De Ferrari · 2020 · Heart
  47. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
    Timotius Ivan Hariyanto, Karunia Valeriani Japar, Felix Kwenandar, Vika Damay, Jeremia Immanuel Siregar, Nata Pratama Hardjo Lugito, Margaret Merlyn Tjiang, Andree Kurniawan · 2020 · The American Journal of Emergency Medicine
  48. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection
    Aleksandra Synowiec, Artur Szczepański, Emilia Barreto-Durán, Laurensius Kevin Lie, Krzysztof Pyrć · 2021 · Clinical Microbiology Reviews
  49. Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19)
    Li Bai, Dawei Yang, Xun Wang, Tong Lin, Xiaodan Zhu, Nanshan Zhong, Chunxue Bai, Charles A. Powell, Rongchang Chen, Jian Zhou et al. · 2020 · Clinical eHealth
  50. COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
    John, Alison E., Joseph, Chitra, Jenkins, Gisli, Tatler, Amanda L. · 2021 · Immunological Reviews
  51. Management and Treatment of COVID-19: The Chinese Experience
    Fujun Peng, Lei Tu, Yongshi Yang, Peng Hu, Runsheng Wang, Qinyong Hu, Feng Cao, Taijiao Jiang, Jinlyu Sun, Guogang Xu et al. · 2020 · Canadian Journal of Cardiology
  52. Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal–Oral Transmission? A COVID-19 Virological and Clinical Review
    Siyuan Ding, T. Jake Liang · 2020 · Gastroenterology
  53. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
    Wang Yin, Weiwei Jiang, Qi He, Cheng Wang, Baoju Wang, Pan Zhou, Nianguo Dong, Qiaoxia Tong · 2020 · Signal Transduction and Targeted Therapy
  54. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
    Anwar Santoso, Raymond Pranata, Arief Wibowo, Makhyan Jibril Al Farabi, Ian Huang, Budhi Antariksa · 2020 · The American Journal of Emergency Medicine
  55. Liver Biochemistries in Hospitalized Patients With COVID‐19
    Patricia Pringle Bloom, Eric Allan Meyerowitz, Zoe Reinus, Michael Daidone, Jenna L. Gustafson, Arthur Y. Kim, Esperance A. K. Schaefer, Raymond T. Chung · 2020 · Hepatology
  56. Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient
    Xiao-Hong Yao, Zhi-Cheng He, Tingyuan Li, Huarong Zhang, Yan Wang, Huaming Mou, Qiao‐Nan Guo, Shi‐Cang Yu, Yanqing Ding, Xindong Liu et al. · 2020 · Cell Research
  57. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis
    Xudong Feng, Shuangshuang Li, Qiang Sun, Jiaqi Zhu, Bo Chen, Maoming Xiong, Guodong Cao · 2020 · Frontiers in Medicine
  58. SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc
    Giuseppe Magro · 2020 · Cytokine X
  59. The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
    José Laerte Boechat, Inês Chora, António Morais, Luís Delgado · 2021 · Pulmonology
  60. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
    Liguori, Claudio, Pierantozzi, Mariangela, Spanetta, Matteo, Sarmati, Loredana, Cesta, Novella, Iannetta, Marco, Ora, Josuel, Mina, Grazia Genga, Puxeddu, Ermanno, Balbi, Ottavia et al. · 2020 · Brain, Behavior, and Immunity
  61. Controversies About COVID-19 and Anticancer Treatment with Immune Checkpoint Inhibitors
    Melissa Bersanelli · 2020 · Immunotherapy
  62. Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response
    Han Zhu, June‐Wha Rhee, Paul P. Cheng, Sarah Waliany, Amy Chang, Ronald M. Witteles, Holden Terry Maecker, Mark M. Davis, Patricia Kim Phuong Nguyen, Sean M. Wu · 2020 · Current Cardiology Reports
  63. Autopsy findings in COVID-19-related deaths: a literature review
    Aniello Maiese, Alice Chiara Manetti, Raffaele La Russa, Marco Di Paolo, Emanuela Turillazzi, Paola Frati, Vittorio Fineschi · 2020 · Forensic Science Medicine and Pathology
  64. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
    Peijie Zhong, Jing Xu, Dong Yang, Yue Liang Shen, Lu Wang, Yun Feng, Chunling Du, Yuanlin Song, Chaomin Wu, Xianglin Hu et al. · 2020 · Signal Transduction and Targeted Therapy
  65. Predictors of COVID-19 severity: a systematic review and meta-analysis
    Mudatsir Mudatsir, Jonny Karunia Fajar, Laksmi Wulandari, Gatot Soegiarto, Muhammad Ilmawan, Yeni Purnamasari, Bagus Aulia Mahdi, Galih Dwi Jayanto, Suhendra Suhendra, Yennie Ayu Setianingsih et al. · 2020 · F1000Research
  66. COVID-19 Infection
    John R. Greenland, Marilyn Diane Michelow, Linlin Wang, Martin J. London · 2020 · Anesthesiology
  67. High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California
    George T. Cholankeril, Alexander Joseph Podboy, Vasiliki Irene Aivaliotis, Branden Tarlow, Edward A. Pham, Sean Paul Spencer, Donghee Kim, Ann W. Hsing, Aijaz Ahmed · 2020 · Gastroenterology
  68. Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
    Bao, Lirong, Zhang, Cheng, Dong, Jiajia, Zhao, Lei, Li, Yan, Sun, Jianxun · 2020 · Frontiers in Microbiology
  69. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)
    Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, Sarah M Lofgren, Caleb P Skipper, Melanie R. Nicol, Matthew F Pullen, Radha Rajasingham, Emily Gibson McDonald, Todd Campbell Lee et al. · 2020 · Open Forum Infectious Diseases
  70. The Immune Response and Immunopathology of COVID-19
    Esmaeil Mortaz, Payam Tabarsi, Mohammad Varahram, Gert Folkerts, Ian Michael Adcock · 2020 · Frontiers in Immunology
  71. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
    Konstantinos E. Farsalinos, Anastasia Barbouni, RAYMOND S. NIAURA · 2020 · Internal and Emergency Medicine
  72. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection
    Min Zheng, Evan Peter Williams, R. K. Subbarao Malireddi, Rajendra Karki, Balaji Banoth, Amanda R. Burton, Richard J. Webby, Rudragouda Channappanavar, Colleen Beth Jonsson, Thirumala‐Devi Kanneganti · 2020 · Journal of Biological Chemistry
  73. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
    SangJoon Lee, Rudragouda Channappanavar, Thirumala‐Devi Kanneganti · 2020 · Trends in Immunology
  74. NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
    Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker, Oliver Planz · 2020 · Frontiers in Immunology
  75. The Conundrum of ‘Long-COVID-19ʹ: A Narrative Review
    Mandeep Kumar Garg, Muniraju Maralakunte, Suruchi Garg, Sahajal Dhooria, Inderpaul Singh Sehgal, Ashu Seith Bhalla, Rajesh Vijayvergiya, Sandeep Grover, Vikas Bhatia, Priya Jagia et al. · 2021 · International Journal of General Medicine
  76. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
    Valentina Morena, Laura Milazzo, Letizia M Oreni, Giovanna Bestetti, Tommaso Fossali, Cinzia Roberta Bassoli, Alessandro Torre, Maria Vittoria Cossu, Caterina Minari, Elisabetta Ballone et al. · 2020 · European Journal of Internal Medicine
  77. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
    Bilian Yu, Xin Li, Jin Chen, Mingqi Ouyang, Hong Zhang, Xinge Zhao, Liang V. Tang, Qin Luo, Min Xu, Lizhen Yang et al. · 2020 · Journal of Thrombosis and Thrombolysis
  78. The COVID-19 pandemic: diverse contexts; different epidemics—how and why?
    Wim V. Damme, Ritwik Dahake, Alexandre Délamou, Brecht Ingelbeen, Edwin Wouters, Guido Vanham, Remco van de Pas, Jean‐Paul Dossou, Por Ir, Ṣẹ̀yẹ Abímbọ́lá et al. · 2020 · BMJ Global Health
  79. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
    De Luca, Giacomo, Cavalli, Giulio, Campochiaro, Corrado, Della-Torre, Emanuel, Angelillo, Piera, Tomelleri, Alessandro, Boffini, Nicola, Tentori, Stefano, Mette, Francesca, Farina, Nicola et al. · 2020 · The Lancet Rheumatology
  80. Analysis of 92 deceased patients with COVID‐19
    Fan Yang, Shaobo Shi, Jiling Zhu, Jinzhi Shi, Kai Dai, Xiaobei Chen · 2020 · Journal of Medical Virology
  81. Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
    Fabio Infusino, Massimiliano Marazzato, Massimo Mancone, Francesco Fedele, Claudio Maria Mastroianni, Paolo Severino, Giancarlo Ceccarelli, Letizia Santinelli, Elena Cavarretta, Antonino G. M. Marullo et al. · 2020 · Nutrients
  82. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
    Rafael B. Polidoro, Robert S. Hagan, Roberta Ribeiro De Santis Santiago, Nathan W. Schmidt · 2020 · Frontiers in Immunology
  83. Epidemiological characteristics of COVID-19: a systematic review and meta-analysis
    Malahat Khalili, Mohammad Karamouzian, Naser Nasiri, Sara Javadi, Ali Mirzazadeh, Hamid Pour Sharifi · 2020 · Epidemiology and Infection
  84. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
    Spinello Antinori, Maria Vittoria Cossu, Anna Lisa Ridolfo, Roberto Rech, Cecilia Bonazzetti, Gabriele Pagani, G. Gubertini, Massimo Coen, Carlo Federico Magni, Antonio Castelli et al. · 2020 · Pharmacological Research
  85. COVID-19 and Asthma: Reflection During the Pandemic
    Shuang Liu, Yuxiang Zhi, Sun Ying · 2020 · Clinical Reviews in Allergy & Immunology
  86. Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
    David Y.W. Lee, Qing Y. Li, Jing Liu, Thomas Efferth · 2020 · Phytomedicine
  87. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China
    Ronghui Du, Limin Liu, Wen Yin, Wen Wang, Lulu Guan, Ming-Li Yuan, Yu-Lei Li, Yi Hu, Xuyan Li, Bing Sun et al. · 2020 · Annals of the American Thoracic Society
  88. CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China
    Xiaoming Li, Wenbing Zeng, Xiang Li, Haonan Chen, Linping Shi, Xinghui Li, Hongnian Xiang, Yang Cao, Hui Chen, Chen Liu et al. · 2020 · Journal of Translational Medicine
  89. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Swatantra Kumar, Rajni Nyodu, Vimal K. Maurya, Shailendra Kumar Saxena · 2020 · Medical virology
  90. Cytokine storm syndrome in coronavirus disease 2019: A narrative review
    Yue-Ming Gao, Gang Xu, Bin Wang, Bi‐Cheng Liu · 2020 · Journal of Internal Medicine
  91. Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
    Barnaby Edward Young, Sean Wei Xiang Ong, Lisa F. P. Ng, Danielle E. Anderson, Wan Ni Chia, Po Ying Chia, Li Wei Ang, Tze Minn Mak, Shirin Kalimuddin, Louis Yi Ann Chai et al. · 2020 · Clinical Infectious Diseases
  92. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China
    Zhilin Zeng, Haijing Yu, Huilong Chen, Weipeng Qi, Liang Chen, Guang Chen, Weiming Yan, Tao Chen, Qin Ning, Meifang Han et al. · 2020 · Critical Care
  93. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
    Sobia Noreen, Irsah Maqbool, Asadullah Madni · 2021 · European Journal of Pharmacology
  94. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
    Lok-Yin Roy Wong, Stanley M. Perlman · 2021 · Nature reviews. Immunology
  95. A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
    Krishna Sriram, Paul A. Insel · 2020 · British Journal of Pharmacology
  96. COVID-19 and the Digestive System
    Chunxiang Ma, Yingzi Cong, Hu Zhang · 2020 · The American Journal of Gastroenterology
  97. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities
    Laura Falasca, Roberta Nardacci, Daniele Colombo, Eleonora Lalle, Antonino Di, Emanuele Nicastri, Andrea Antinori, Nicola Petrosillo, Luisa Marchioni, Gianluigi Biava et al. · 2020 · The Journal of Infectious Diseases
  98. Over-ordering and food waste: The use of food delivery apps during a pandemic
    Rajat Kumar Sharma, Amandeep Dhir, Shalini Talwar, Puneet Kaur · 2021 · International Journal of Hospitality Management
  99. Perceived Risk of COVID-19 Pandemic: The Role of Public Worry and Trust
    Mohsen Khosravi · 2020 · Electronic Journal of General Medicine
  100. The impact of coronavirus infectious disease 19 (COVID‐19) on oral health
    Arkadiusz Marian Dziedzic, Robert Dariusz Wojtyczka · 2020 · Oral Diseases